$SUNSHINE PHARMA(06887.HK) has the cash flow from flu drugs as a foundation, while $JACOBIO-B(01167.HK), $INNOGEN-B(02591.HK), and $HJ SCIENCE-B(06132.HK) are pure pipeline stocks—the story of innovative drugs going global has been told for a year and is still being renewed. The rise and fall of stocks with a 'B' suffix all depend on the mood of clinical data 🥲
The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
